News and Announcements
Spotlight Reporting Appoints David New as Director of Strategic Relationships
- Published January 14, 2016 11:39AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Spotlight Reporting have appointed Sydney-based David New as our Director of Strategic Relationships. David comes to us with an impressive track record in software, from an MD role at Attache, National Sales Director at Xero and most recently as Country Manager, Australia and New Zealand at Receipt Bank.
ABOUT SPOTLIGHT REPORTING
Spotlight Reporting is an innovative SaaS business intelligence reporting company. Our family of four products import data from leading financial and non-financial software applications to automatically create powerful management reports, dashboards, forecasts and multi entity reporting – saving time and effort while also delivering insight and clarity for accountants and business owners. The world’s largest accounting brands use our software, as do thousands of organisations across 40 countries.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
